PLEASANTON, Calif., Feb. 7 SpectraGenics, a leader inlight-based therapeutic beauty devices, today announced over-the-counter (OTC)clearance from the United States Food and Drug Administration (FDA) for theirpatented hand-held laser hair removal device designed for at-home use. TheTRIA is the first hair removal laser to enter the U.S. home-based devicemarket, an industry projected to grow exponentially over the next three years.
"The FDA clearance is the culmination of many years of research, clinicaltesting and innovative product design efforts," said Robert Grove, PhD, CEO,SpectraGenics. "Our engineers are the same scientists who developed the firstand gold-standard professional diode laser hair removal system over 10 yearsago which is still used by physicians nationwide. We've invested significantresources to harness that same light-based technology to deliver a safe,effective way for consumers to treat unwanted hair in the privacy of theirhomes."
The TRIA device is the first at-home device to feature a diode laserspecially designed to be safe and effective for at-home use. SpectraGenicshas been selling a version of the TRIA, called i-Epi, in Japan since 2005.The TRIA is the first in a series of at-home science-based beauty devices tobe pioneered by SpectraGenics.
"I have been performing laser hair removal in my office for 12 years andwelcome the arrival of TRIA as an adjunct to professional laser hair removal,"said Eric F. Bernstein, MD, Clinical Associate Professor at the University ofPennsylvania. "TRIA is simple, safe and very effective. Many of my patientswill be able to use TRIA for touch-ups in between visits as well as on otherareas not treated in-office to achieve and maintain beautiful results, and Iexpect it to increase the number of patients I see for laser hair removal.The TRIA was developed by the engineers who created the diode hair removallaser I use in my office today."
Professional laser hair removal is consistently the leading non-surgicalcosmetic treatment for women 34 years and under, and the second most popularprocedure for women over 35, according to the American Society for AestheticPlastic Surgery. The at-home device market is relatively new and expected togrow exponentially with the introduction of products targeted for treatment ofhair, acne, wrinkles and skin rejuvenation.
TRIA will be available Spring 2008 from medical professionals and selectretailers, as well as online at www.triabeauty.com.
SpectraGenics, Inc., the leader in light-based therapeutic beauty devices,gives men and women the freedom to incorporate clinically-proven aesthetictechnologies into their personal care regimen. In 1993 Robert Grove, Ph.D.,and a team of American dermatologists and engineers developed the first diodelaser for hair removal utilized by physicians in their medical practices. In2003, these individuals founded SpectraGenics, Inc. and assembled aninternationally renowned team of experts in the field of aesthetic lasers tobegin the development of its flagship TRIA device and future innovations inscience-driven consumer beauty products.
SOURCE SpectraGenics, Inc.